Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06609161 · ClinicalTrials.gov registry record · Phase 1
A Study to Compare Oral Formulations of Tedizolid Phosphate in Healthy Adults (MK-1986-044)
A Phase 1 study, sponsored by Merck Sharp & Dohme.
- Completed
- Registry status
- Phase 1
- Development phase
- 18
- Enrollment target
NCT06609161 is a Phase 1 study that has completed, run by Merck Sharp & Dohme. The registered enrollment target is 18 participants.
The verdict
NCT06609161, a Phase 1 study, has completed, sponsored by Merck Sharp & Dohme.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 18 participants
- Enrollment target
Study Summary
The goal of the study is to learn what happens to different oral formulations of tedizolid phosphate (MK-1986) in a healthy person's body over time. Researchers want to know if there is a difference in the oral formulations absorption and elimination from the healthy persons body.
Interventions
- DRUG Tedizolid Phosphate Oral Formulation 1 (Reference)
- DRUG Tedizolid Phosphate Oral Formulation 2 (Test)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2024-07-16 |
| Est. Completion | 2024-08-08 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06609161
The ClinicalTrials.gov registry entry for NCT06609161 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 18 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Merck Sharp & Dohme, which has 558 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Tedizolid Phosphate Oral Formulation 1 (Reference) is the first listed.
NCT06609161 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06609161 about?
NCT06609161 is a clinical study titled "A Study to Compare Oral Formulations of Tedizolid Phosphate in Healthy Adults (MK-1986-044)". The goal of the study is to learn what happens to different oral formulations of tedizolid phosphate (MK-1986) in a healthy person's body over time. Researchers want to know if there is a difference in the oral formulations absorption and elimination from the healthy persons body.
What is the current status of trial NCT06609161?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 18 participants. The study started on 2024-07-16. Estimated completion is 2024-08-08.
What interventions are being tested in trial NCT06609161?
The interventions under investigation include: Tedizolid Phosphate Oral Formulation 1 (Reference) (DRUG), Tedizolid Phosphate Oral Formulation 2 (Test) (DRUG).
Who is sponsoring clinical trial NCT06609161?
This trial is sponsored by Merck Sharp & Dohme, which has 558 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.